[go: up one dir, main page]

HRP20020111B1 - Pharmaceutical composition containing fenofibrate and preparation method - Google Patents

Pharmaceutical composition containing fenofibrate and preparation method

Info

Publication number
HRP20020111B1
HRP20020111B1 HR20020111A HRP20020111A HRP20020111B1 HR P20020111 B1 HRP20020111 B1 HR P20020111B1 HR 20020111 A HR20020111 A HR 20020111A HR P20020111 A HRP20020111 A HR P20020111A HR P20020111 B1 HRP20020111 B1 HR P20020111B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical composition
surfactant
preparation
composition containing
cellulose derivative
Prior art date
Application number
HR20020111A
Other languages
English (en)
Inventor
Criere Bruno
Suplie Pascal
Chenevier Philippe
Original Assignee
Laboratoires Des Produits Ethiques Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020111(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Des Produits Ethiques Ethypharm filed Critical Laboratoires Des Produits Ethiques Ethypharm
Publication of HRP20020111A2 publication Critical patent/HRP20020111A2/hr
Publication of HRP20020111B1 publication Critical patent/HRP20020111B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20020111A 1999-07-09 2000-07-07 Pharmaceutical composition containing fenofibrate and preparation method HRP20020111B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908923A FR2795961B1 (fr) 1999-07-09 1999-07-09 Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
PCT/FR2000/001971 WO2001003693A1 (fr) 1999-07-09 2000-07-07 Composition pharmaceutique contenant du fenofibrate et procede de preparation

Publications (2)

Publication Number Publication Date
HRP20020111A2 HRP20020111A2 (en) 2003-04-30
HRP20020111B1 true HRP20020111B1 (en) 2005-12-31

Family

ID=9547923

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020111A HRP20020111B1 (en) 1999-07-09 2000-07-07 Pharmaceutical composition containing fenofibrate and preparation method

Country Status (37)

Country Link
US (4) US7101574B1 (de)
EP (3) EP1523983B1 (de)
JP (2) JP4841092B2 (de)
KR (3) KR20020025188A (de)
CN (2) CN1682707B (de)
AT (3) ATE341320T1 (de)
AU (1) AU782282B2 (de)
BG (1) BG65504B1 (de)
BR (1) BR0012335A (de)
CA (1) CA2377909C (de)
CY (1) CY1106206T1 (de)
CZ (1) CZ300094B6 (de)
DE (3) DE60039313D1 (de)
DK (3) DK1523983T3 (de)
EA (1) EA004294B1 (de)
EE (1) EE04995B1 (de)
ES (3) ES2235919T3 (de)
FR (1) FR2795961B1 (de)
GE (1) GEP20043287B (de)
HK (1) HK1044894B (de)
HR (1) HRP20020111B1 (de)
HU (1) HU229044B1 (de)
IL (2) IL147499A0 (de)
IS (1) IS2157B (de)
ME (1) ME01361B (de)
MX (1) MXPA02000324A (de)
NO (1) NO333301B1 (de)
NZ (1) NZ516416A (de)
PL (1) PL212082B1 (de)
PT (3) PT1574214E (de)
RS (1) RS50035B (de)
SI (2) SI1194140T1 (de)
SK (1) SK287484B6 (de)
TR (1) TR200200008T2 (de)
UA (1) UA72925C2 (de)
WO (1) WO2001003693A1 (de)
ZA (1) ZA200200169B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
SI1551372T1 (en) * 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
EP1553928A1 (de) * 2002-09-24 2005-07-20 Ranbaxy Laboratories, Ltd. Orale pharmazeutische zusammensetzungen von fenofibrat mit hoher bioverfügbarkeit
CN100367947C (zh) * 2002-12-04 2008-02-13 徐州恩华赛德药业有限责任公司 具有抗高血脂症的含非诺贝特的药物组合物
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
MXPA05005736A (es) * 2002-12-17 2005-08-16 Abbott Gmbh & Co Kg Formulacion que comprende acido fenofibrico, una sal fisiologicamente aceptable o derivado del mismo.
EP1832285A1 (de) * 2002-12-17 2007-09-12 Abbott GmbH & Co. KG Formulierung mit Fenofibrinsäure oder einem physiologisch verträglichen Salz davon
MXPA06000111A (es) * 2003-07-02 2006-04-27 Abbott Lab Proceso para preparar formulaciones de farmacos que regulan lipidos.
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
WO2006089674A2 (en) * 2005-02-25 2006-08-31 F.Hoffmann-La Roche Ag Tablets with improved drug substance dispersibility
CN101212962A (zh) * 2005-03-30 2008-07-02 特瓦制药工业有限公司 包含薄荷醇或peg/泊洛沙姆的非诺贝特的改进制剂
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
US20090210197A1 (en) * 2006-05-23 2009-08-20 Intelemetrix Ltd Data accessing system and method
DK2719378T3 (en) 2006-06-19 2016-10-17 Alpharma Pharmaceuticals Llc pharmaceutical compositions
KR100767349B1 (ko) * 2006-08-01 2007-10-17 삼천당제약주식회사 페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (de) * 2006-09-27 2008-05-21 Novartis AG Pharmazeutische Zusammensetzung umfassend Nilotinib oder dessen Salz
AU2007322269A1 (en) * 2006-10-11 2008-05-29 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
JP4993274B2 (ja) * 2006-12-05 2012-08-08 日医工株式会社 フェノフィブラート含有製剤組成物の製造方法
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2009079521A1 (en) * 2007-12-17 2009-06-25 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
FR2940118B1 (fr) * 2008-12-24 2013-08-09 Ethypharm Sa Formulation pharmaceutique de fenofibrate nanonise
JPWO2010092925A1 (ja) * 2009-02-12 2012-08-16 あすか製薬株式会社 固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) * 2009-03-06 2010-11-10 安徽省药物研究所 非诺贝特药物组合物
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) * 2010-04-12 2012-11-21 한미사이언스 주식회사 페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) * 2011-09-07 2014-09-11 Ethypharm Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) * 2012-05-29 2013-12-05 주식회사 브이터치 프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en) 2012-06-25 2014-05-13 Mylan, Inc. Fenofibrate formulation
WO2014091318A1 (en) 2012-12-11 2014-06-19 Lupin Atlantis Holdings, S.A. Reduced dose pharmaceutical compositions of fenofibrate
JP6174806B2 (ja) * 2013-12-04 2017-08-02 ダウ グローバル テクノロジーズ エルエルシー セルロース誘導体及び液体希釈剤の混合物を調製するためのプロセス
CN104352466A (zh) * 2014-11-17 2015-02-18 辰欣药业股份有限公司 一种非诺贝特组合物及其制剂
CN107961224B (zh) * 2017-12-06 2021-05-04 齐鲁制药(海南)有限公司 一种阿昔替尼片及其制备方法
KR102407512B1 (ko) 2019-10-30 2022-06-13 주식회사 대웅테라퓨틱스 피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) * 2020-09-25 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物及其制备方法
WO2022071768A1 (en) * 2020-09-29 2022-04-07 Addpharma Inc. A pharmaceutical composition comprising fenofibrate particles with improved bioavailability
CN112121023A (zh) * 2020-09-30 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543472A (fr) 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
US4058552A (en) 1969-01-31 1977-11-15 Orchimed Sa Esters of p-carbonylphenoxy-isobutyric acids
GB1579818A (en) 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
DE2966564D1 (en) 1978-11-20 1984-02-23 American Home Prod Therapeutic compositions with enhanced bioavailability and process for their preparation
FR2494112B1 (de) * 1980-11-19 1986-01-10 Laruelle Claude
GB8414220D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
GB8414221D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Unit dosage form
FR2602423B1 (fr) 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en) 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
US4895725A (en) * 1987-08-24 1990-01-23 Clinical Technologies Associates, Inc. Microencapsulation of fish oil
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
HU219341B (en) 1990-07-02 2001-03-28 Roche Diagnostics Gmbh Process for producing pressed, moulded, delayed release dose units and dose units thus produced
JP3125221B2 (ja) * 1990-09-01 2001-01-15 大正製薬株式会社 ソファルコン含有固形製剤
JP3037393B2 (ja) * 1990-10-22 2000-04-24 大正薬品工業株式会社 経口投与用固形薬剤の製造方法
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
ATE156707T1 (de) * 1991-06-21 1997-08-15 Ilsan Ilac Ve Hammaddeleri San Neues galenisches verfahren für omeprazol enthaltende pellets
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr) 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de) 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
JP2000514059A (ja) * 1996-06-28 2000-10-24 シェーリング コーポレイション トリアゾール抗真菌化合物を含む経口組成物
FR2758461A1 (fr) 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
AU2005299A (en) * 1997-12-20 1999-07-12 Genencor International, Inc. Fluidized bed matrix granule
JP2000086509A (ja) * 1998-09-14 2000-03-28 Taisho Yakuhin Kogyo Kk ソファルコン含有製剤の製造方法
FR2783421B1 (fr) * 1998-09-17 2000-11-24 Cll Pharma Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) * 1999-06-11 2002-04-09 Abbott Laboratories Formulations comprising lipid-regulating agents
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US6667064B2 (en) 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
ATE367802T1 (de) * 2000-09-20 2007-08-15 Jagotec Ag Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate

Also Published As

Publication number Publication date
SK287484B6 (sk) 2010-11-08
NO20020014L (no) 2002-03-04
PL352307A1 (en) 2003-08-11
EP1194140B1 (de) 2005-03-30
CZ300094B6 (cs) 2009-01-28
CN1360499A (zh) 2002-07-24
EA200200147A1 (ru) 2002-06-27
GEP20043287B (en) 2004-07-26
PL212082B1 (pl) 2012-08-31
EE200200011A (et) 2003-02-17
FR2795961B1 (fr) 2004-05-28
CN1204885C (zh) 2005-06-08
ATE341320T1 (de) 2006-10-15
SI1194140T1 (en) 2005-06-30
US8658212B2 (en) 2014-02-25
KR20070026716A (ko) 2007-03-08
HK1044894A1 (en) 2002-11-08
IS6218A (is) 2002-01-03
EP1574214A1 (de) 2005-09-14
HU229044B1 (hu) 2013-07-29
EE04995B1 (et) 2008-04-15
US20110159082A1 (en) 2011-06-30
SK152002A3 (en) 2002-07-02
IL147499A (en) 2007-03-08
MXPA02000324A (es) 2002-06-21
EP1523983A1 (de) 2005-04-20
DK1194140T3 (da) 2005-07-04
IS2157B (is) 2006-11-15
NO20020014D0 (no) 2002-01-02
BG106280A (en) 2002-08-30
EP1574214B1 (de) 2006-10-04
US20080248101A1 (en) 2008-10-09
FR2795961A1 (fr) 2001-01-12
AU6296000A (en) 2001-01-30
ZA200200169B (en) 2002-07-31
AU782282B2 (en) 2005-07-14
CZ20022A3 (cs) 2002-05-15
CN1682707B (zh) 2010-05-05
NZ516416A (en) 2003-10-31
ES2235919T3 (es) 2005-07-16
EA004294B1 (ru) 2004-02-26
KR20020025188A (ko) 2002-04-03
KR20060073549A (ko) 2006-06-28
DE60019120D1 (de) 2005-05-04
NO333301B1 (no) 2013-04-29
HK1080391A1 (en) 2006-04-28
BG65504B1 (bg) 2008-10-31
ES2271924T3 (es) 2007-04-16
KR100766644B1 (ko) 2007-10-15
DE60019120T2 (de) 2006-02-09
ATE291912T1 (de) 2005-04-15
HK1044894B (zh) 2005-06-24
DE60031184D1 (de) 2006-11-16
EP1523983B1 (de) 2008-06-25
RS50035B (sr) 2008-11-28
US20070071812A1 (en) 2007-03-29
YU93201A (sh) 2004-09-03
JP2011148813A (ja) 2011-08-04
IL147499A0 (en) 2002-08-14
TR200200008T2 (tr) 2002-06-21
EP1194140A1 (de) 2002-04-10
UA72925C2 (uk) 2005-05-16
PT1574214E (pt) 2007-01-31
WO2001003693A1 (fr) 2001-01-18
PT1523983E (pt) 2008-09-19
ATE399006T1 (de) 2008-07-15
ME01361B (me) 2008-11-28
SI1574214T1 (sl) 2006-12-31
BR0012335A (pt) 2002-03-19
CY1106206T1 (el) 2011-06-08
HRP20020111A2 (en) 2003-04-30
ES2309438T3 (es) 2008-12-16
CA2377909C (fr) 2011-06-28
CN1682707A (zh) 2005-10-19
JP4841092B2 (ja) 2011-12-21
CA2377909A1 (fr) 2001-01-18
HUP0202338A2 (en) 2002-10-28
DE60031184T2 (de) 2007-08-23
DK1574214T3 (da) 2007-01-22
PT1194140E (pt) 2005-07-29
JP2003504331A (ja) 2003-02-04
DE60039313D1 (de) 2008-08-07
US7101574B1 (en) 2006-09-05
HK1074588A1 (zh) 2005-11-18
HUP0202338A3 (en) 2003-03-28
US8563042B2 (en) 2013-10-22
DK1523983T3 (da) 2008-10-13

Similar Documents

Publication Publication Date Title
HRP20020111B1 (en) Pharmaceutical composition containing fenofibrate and preparation method
HUT52030A (en) Fungicide, insecticide and miticide compositions containing propene-carboxylic acid derivatives as active components and process for producing the active components
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
BR0012250A (pt) Processo de fabricação de grânulos revestidos com gosto mascarado, e liberação imediata do princìpio ativo, grânulo revestido, comprimido multiparticulado de dissolução rápida e comprimido de hidrodispersibilidade rápida
EP0326357A3 (de) Avermectinderivate
WO2001029055A3 (fr) Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
EA199700093A1 (ru) ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК
HUP9802995A3 (en) Substituted sulphonylamino (thio)carbonyl derivatives, intermediates, thereof herbicide compositions containing these compounds as active ingredients, process for the preparation and use of the compounds and compositions
EP2065451A3 (de) Trockenpräparate
BG102555A (en) Microgranules of delayed release containing dilthiazem as active component
EP1020444A4 (de) 6-phenoxypicolinsäure, alkylidenhydrazid-derivate, verfahren zu ihrer herstellung und herbizide
HUP9601321A2 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
EP1059304A4 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
AU692030B2 (en) Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients
TR199901044T2 (en) Endos�lfan-mikrokaps�l da��l�m�.
AU677262B2 (en) N-acyl-n-phenylmaleamic acid derivative, process for producing the same, and herbicide containing the same as active ingredient
AU2178299A (en) 8-azabicyclo(3.2.1)oct-2-ene derivatives as pesticides

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: ETHYPHARM, FR

ODRP Renewal fee for the maintenance of a patent

Payment date: 20180620

Year of fee payment: 19

PBON Lapse due to non-payment of renewal fee

Effective date: 20190707